Tag:
clazosentan
Latest Headlines
Latest Headlines
Actelion brain hemorrhage drug misses goal
Switzerland's Actelion has reported that its potential blockbuster drug clazosentan for treatment of aneurysmal subarachnoid hemorrhage has failed a late-stage trial, causing analysts to doubt
